It is conceivable that K-Ras mutations, which are frequently present in pancreatic adenocarcinomas (Hruban et al, 1993) lead to an activation of NF-κB transcriptional activity (Finco et al, 1997). Here, KRAS is linked to pancreatic adenocarcinoma.